↑
sikakoiralta taas pelkkää roskaa. Yrititkö tuolla TimesofIndian artikkelilla todistaa jotain? Eihän edes siellä sanottu niin kuten väität.
Tässä faktaa:
Is Pfizer Making Copy Of Ivermectin To Treat COVID-19?
Fact #1 : Pfizer Is Not Making A Copy Of Ivermectin.
Fact #2 : Pfizer Is Making Two Protease Inhibitors.
Pfizer scientists are working on two SARS-CoV-2 protease inhibitors :
* PF-07321332, which is orally administered, and
* PF-07304814, which is intravenously-administered.
They are both not related to ivermectin, which is an anti-parasitic drug derived from the Streptomyces avermitilis bacteria.
Fact #3 : Ivermectin Works Differently From Protease Inhibitors.
Ivermectin works by binding to, and opening, the glutamate-gated chloride channels of nerve and muscle cells, increasing the flow of chloride ions that paralyses the affected tissue.
The Pfizer protease inhibitors work by binding to proteolytic enzymes used by the SARS-CoV-2 virus to replicate. This prevents the virus from replicating in the infected cells, stopping the infection and preventing transmission.
Fact #4 : There Is No Censorship Of Ivermectin.
Fact #5 : Ivermectin Not Proven To Work Against COVID-19.
Ivermectin has been shown to work against COVID-19 in lab (in vitro) studies, but does NOT improve clinical outcomes or prevent transmission.
That is why the WHO and the vast majority of health authorities around the world DO NOT advocate using ivermectin to prevent or treat COVID-19.
https://www.techarp.com/science/lancet- ... udy/?amp=1
https://www.thelancet.com/journals/ecli ... X/fulltext
https://www.thelancet.com/journals/ecli ... 8/fulltext
Fact #6 : New Drugs Require Approval.
It doesn’t make sense for Pfizer to make a patentable copy of ivermectin. Unless it is significantly better than ivermectin, no one will buy their patented copy of ivermectin.
It would also require considerable resources for them to get the new “ivermectin copy” tested and approved.
If ivermectin really works, it would be better for Pfizer to simply produce ivermectin. After all, they no longer need to pay Merck for the patent!
https://i0.wp.com/www.techarp.com/wp-co ... C180&ssl=1
Valmistajan kommentti Stromectolin (ivermectin) käytöstä Covid 19 vastaan:
Merck Statement on Ivermectin use During the COVID-19 Pandemic:
Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:
* No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
* No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
* A concerning lack of safety data in the majority of studies.
We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.
https://www.merck.com/news/merck-statem ... -pandemic/
Brasiliassa tietty alue ei tilastollisesti hyötynyt yhtikäs mitään ivermectinistä verrattuna alueeseen, jossa sitä ei käytetty.
Ivermectin against COVID-19: The unprecedented consequences in Latin America.
https://www.sciencedirect.com/science/a ... via%3Dihvb
Delhin tutkijoiden AIIMS-tutkimuksessa parasiittilääke Ivermektiini ei ole vähentänyt covid-19-potilailla viruskuormaa ja oireiden kestoa edes suuremmilla annoksilla.
Ivermectin doesn’t cut viral load in Covid-19 patients, AIIMS study shows.
https://www.hindustantimes.com/cities/d ... 15515.html
